Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | PPARG | P37231 | 7/20 | 0.42 |
| ▸ | PPARD | Q03181 | 7/20 | 0.42 |
| ▸ | PPARA | Q07869 | 7/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27489305 | 0.93 | FFAR4 (0.51) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL28184414 | 0.93 | FFAR4 (0.51) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL28183595 | 0.93 | AKR1B1 (0.43) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL27488993 | 0.89 | FFAR4 (0.51) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL27502586 | 0.89 | FFAR4 (0.51) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL28740584 | 0.89 | FFAR4 (0.51) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL27507235 | 0.89 | FFAR4 (0.51) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL6515414 | 0.89 | AKR1B1 (0.43) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL11417018 | 0.87 | AKR1B1 (0.45) | AKR1B1PLA2G2CGPR84PPARGPPARD | |
| SCHEMBL8982621 | 0.86 | FFAR4 (0.61) | AKR1B1GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111202-B2 | Production of salts of 4-hydroxybutyrate using biobased raw materials | CJ CHEILJEDANG CORPORATION (KR) | 2021-09-07 | — | — | US | disclosed |
| EP-2961738-B1 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | CJ CHEILJEDANG CORP (KR) | 2019-12-25 | — | — | EP | disclosed |
| US-20190135729-A1 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | CJ CHEILJEDANG CORPORATION (KR) | 2019-05-09 | — | — | US | disclosed |
| CN-104755510-B | Ziegler natta catalyst system of internal donor and preparation method thereof is used as comprising 1,2 phenylene diester | 印度石油有限公司 | 2017-11-07 | — | — | CN | disclosed |
| US-20160068463-A1 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | CJ CHEILJEDANG CORPORATION (KR) | 2016-03-10 | — | — | US | disclosed |
| EP-2961738-A2 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | Metabolix, Inc. (US) | 2016-01-06 | — | — | EP | disclosed |
| WO-2014078014-A2 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | METABOLIX, INC. (US) | 2014-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160068463-A1 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | HBB, HMBS, AGL | AKR1B1 329/4885PLA2G2C 1740/4885GPR84 1840/4885 |
| US-20190135729-A1 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | HBB, HMBS, AGL | AKR1B1 329/4885PLA2G2C 1740/4885GPR84 1840/4885 |
| US-11111202-B2 | Production of salts of 4-hydroxybutyrate using biobased raw materials | HBB, HMBS, AGL | AKR1B1 329/4885PLA2G2C 1740/4885GPR84 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.